Nasolabial Folds

3

Review clinical trials related to Nasolabial Folds. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds

The purpose of this study is to confirm the long-term safety, effectiveness, and degradation profile of RADIESSE® Injectable Implant for the correction of moderate to severe nasolabial folds (NLFs) in Chinese adults. Eligible participants will receive treatment with RADIESSE® Injectable Implant in both NLFs and may receive an optional touch-up treatment at Month 1 at investigator's discretion. Participants will be followed for up to 24 months after last treatment.

Participants needed: 163
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Merz North America, Inc.Updated: Oct 5, 2026
Eligibility criteria

WSRS score of 3 (moderate) or 4 (severe) in both right and left NLFs, as determi... [+1]

Prior dermal filler or implant material detectable in the NLF area by ultrasound... [+5]

Status: Not yet recruiting

Dermal Evaluation of Facetem™ S in Nasolabial Folds Esthetics Improvement: DEFINE Study

This is a multicenter, prospective, non-randomized, uncontrolled post-market clinical follow-up (PMCF) study designed to evaluate the performance and safety of Facetem S dermal filler for the correction of moderate-to-severe nasolabial folds in adult subjects. Subjects will receive Facetem S treatment at baseline, with an optional touch-up treatment approximately 4 weeks later if clinically necessary. Subjects will be followed for up to 12 months after the final injection to assess wrinkle severity improvement, overall aesthetic improvement, and safety.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: CGBio Inc.Updated: Oct 2, 2026Locations: 5
Eligibility criteria

Male or female, over the age of 18. [+5]

Any history of treatment with permanent or non-absorbable facial fillers, includ... [+17]

Status: Recruiting

Study to Assess Adverse Events and How Effective NOA LIFT is Compared to JUVÉDERM VOLIFT With Lidocaine for the Correction of Nasolabial Folds in Adults

Nasolabial folds (NLFs) are wrinkles that run from the sides of the nose to the corners of the mouth. The goal of this study is to evaluate how safe and effective NOA LIFT is compared to JUVÉDERM VOLIFT with Lidocaine for correcting moderate to severe nasolabial folds in adults. NOA LIFT and JUVÉDERM VOLIFT with Lidocaine are hyaluronic acid-based dermal fillers being evaluated for the treatment of nasolabial folds. Participants are randomly placed into 1 of 2 treatment groups. There is a 2 in 3 chance that participants will be assigned to the NOA LIFT group and a 1 in 3 chance of being assigned to the VOLIFT group. Around 288 adult participants with moderate to severe nasolabial folds will be enrolled at multiple sites in China. Participants will receive deep dermis injections of either NOA LIFT or JUVÉDERM VOLIFT. The study duration is approximately 12 months after the initial treatment. There may be higher treatment burden for participants in this trial compared to their standard of care due to study procedures. Participants will attend regular visits during the study at a hospital or clinic. The effects of the treatment will be checked by medical assessments, vital signs, laboratory tests, vision assessments, checking for side effects, and completing questionnaires.

Participants needed: 288
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: AbbVieUpdated: Aug 31, 2026Locations: 6
Eligibility criteria

Current cutaneous or mucosal inflammatory or infectious processes, abscess, unhe... [+1]